Veradermics

📍 New Haven, United States🗓 Founded 2019👥 43 employees💰 Last funded Nov 2024
Pharmaceutical Manufacturing🌐 veradermics.com
Website LinkedIn
Veradermics is a late clinical-stage biopharmaceutical company founded by dermatologists with direct clinical experience in the treatment of pattern hair loss, a chronic condition that affects 50 million men and 30 million women in the US alone. Our team combines dermatology expertise, clinical research leadership, and biotechnology innovation to advance new solutions and help bring clarity, evidence, and reliability to pattern hair loss. Our mission: to set a new standard in pattern hair loss by developing treatments rooted in real evidence. Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in men and women. Pattern hair loss is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years. Learn more at www.veradermics.com
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Veradermics?
Veradermics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Veradermics last raise funding?
The most recent investment in Veradermics recorded on gritt.io was in November 2024.
When was Veradermics founded?
Veradermics was founded in 2019.
What industry is Veradermics in?
Veradermics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Veradermics based?
Veradermics is headquartered in New Haven, United States.